Global Humanized Antibody Market Research Report 2024

Humanized antibodies mainly refer to antibodies re-expressed by gene cloning and DNA recombination technology of mouse monoclonal antibodies, most of the amino acid sequences of which are replaced by human sequences, and reducing the Its heterogeneity is beneficial to the human body.The constant region part (ie, CH and CL regions) of humanized antibody are encoded by human antibody genes. Human antibodies can greatly reduce the immune side effects of heterologous antibodies on the human body.

The global Humanized Antibody market was valued at US$ 204 million in 2023 and is anticipated to reach US$ 355.1 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.

The humanized antibody market was witnessing steady growth, primarily due to the rising demand for targeted therapies in the treatment of cancer, autoimmune diseases, and other medical conditions. The market featured a mix of large pharmaceutical companies, biotechnology firms, and specialized antibody developers.

Major players

like Roche, Novartis, and Johnson & Johnson were actively involved in the development and commercialization of humanized antibodies. Opportunities existed for humanized antibodies in the field of oncology, where targeted therapies were gaining prominence. There was a growing focus on using humanized antibodies to treat autoimmune diseases like rheumatoid arthritis and multiple sclerosis.

This report aims to provide a comprehensive presentation of the global market for Humanized Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humanized Antibody.

Report Scope

The Humanized Antibody market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Humanized Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Humanized Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation


By Company


Amgen

MorphoSys

Huston BioConsulting LLC

Seattle Genetics

Zyngenia

Genentech

ImmunoGen

Sandoz International

MRC Laboratory of Molecular Biology


Segment by Type


Chimeric Antibody

Modified Antibody


Segment by Application


Laboratory Research

Clinical Drugs


Consumption by Region


North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Humanized Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Humanized Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Frequently Asked Questions